FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:2641-2644 June 12, 2008 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Hannan, E. L. PubMed Citation

To the Editor: Hannan et al. (Jan. 24 issue)¹ are to be commended for appropriately selecting patients with multivessel coronary disease for stenting or bypass surgery. Their clinical judgment ensured that unadjusted survival rates were equal in the two groups, even among patients with diabetes.

The authors attempt to equalize the two groups by evaluating risk-adjusted survival. However, they endeavor to adjust an unadjustable characteristic — the judgment of the treating physician, which is uncorrectable by adjusting for simple clinical variables. Although propensity analyses are valuable in assessing differences between groups, propensity-score matching might have been more enlightening.²

Meta-analyses of . . . [Full Text of this Article]

This article has been cited by other articles:

• Onuma, Y., Kukreja, N., Piazza, N., Eindhoven, J., Girasis, C., Schenkeveld, L., van Domburg, R., Serruys, P. W., Interventional Cardiologists of the Thoraxcenter (, (2009). The Everolimus-Eluting Stent in Real-World Patients: 6-Month Follow-Up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) Registry. J Am Coll Cardiol 54: 269-276 [Abstract] [Full Text]